Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03634124Phase 3Completed
Phase 3, single-arm trial, sponsored by CHU Nîmes. Primary endpoints: Numerical ratio between the value of the thrombin generation test performed without soluble thrombomodulin and the value of the thrombin generation test performed in the presence of soluble… at Day 0, Occurrence of Symptomatic pulmonary embolism at Day 7 and 2 more. Started Feb 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03634124.